Protracted Intraventricular Infusion of Gemcitabine to Circumvent the Blood Brain Barrier
Anticancer Research · 2026
DOI: 10.21873/anticanres.18336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Bruno Chauffert und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Onco-hematology, Centre Hospitalier, Saint Quentin, France; b.chauffert@ch-stquentin.fr. Hauptthemen laut MEDLINE: Deoxycytidine, Blood-Brain Barrier, Antimetabolites, Antineoplastic, Glioblastoma.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Onco-hematology, Centre Hospitalier, Saint Quentin, France; b.chauffert@ch-stquentin.fr.
- Department of Biochemistry, CHU Amiens, UR7516 UPJV, Amiens, France; Galmiche.antoine@chu-amiens.fr.
- Department of Biochemistry, CHU Amiens, UR7516 UPJV, Amiens, France.
- Department of Pharmacology and Toxicology, CHU Besançon, Besançon, France.
- Veterinary Clinic, Nuits Saint George, France.
- Department of Pathology, CHU Amiens, Amiens, France.
Zitieren
APA
Chauffert, B., Galmiche, A., Louandre, C., Royer, B., Simonet, M., Guilain, N., Rech, F., Simonet, P., Sibert, M., Abdaoui, A., Cau, A., Boone, M., & Beaurain, J. (2026). Protracted Intraventricular Infusion of Gemcitabine to Circumvent the Blood Brain Barrier. Anticancer Research. https://doi.org/10.21873/anticanres.18336
Vancouver
Chauffert B, Galmiche A, Louandre C, Royer B, Simonet M, Guilain N, et al. Protracted Intraventricular Infusion of Gemcitabine to Circumvent the Blood Brain Barrier. Anticancer Research. 2026. doi:10.21873/anticanres.18336
BibTeX
@article{Chauffert2026,
author = {Chauffert, Bruno and Galmiche, Antoine and Louandre, Christophe and Royer, Bernard and Simonet, Michel and Guilain, Nelly and Rech, Fabien and Simonet, Pierre and Sibert, Maxime and Abdaoui, Ahmed and Cau, Alexandre and Boone, Mathieu and Beaurain, Jacques},
title = {Protracted Intraventricular Infusion of Gemcitabine to Circumvent the Blood Brain Barrier},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18336}
}
EUVIMED